Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Exact Sciences News

    58,85 € -1,39% -0,83 €
    09:14:18 Uhr Gettex aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 590273
    ISIN: US30063P1057
    US-Symbol: EXAS
    Typ: Aktie

    Exact Sciences News

    07.01.24 - PR Newswire
    Exact Sciences Announces Preliminary Fourth Quarter 2023 Results
    Exact Sciences Announces Preliminary Fourth Quarter 2023 Results PR Newswire
    02.01.24 - PR Newswire
    Exact Sciences to participate in J.P. Morgan Healthcare Conference
    Exact Sciences to participate in J.P. Morgan Healthcare Conference PR Newswire
    07.12.23 - PR Newswire
    Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings
    Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings PR Newswire
    01.12.23 - PR Newswire
    Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
    Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients PR Newswire
    30.11.23 - PR Newswire
    Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
    Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients PR Newswire
    17.11.23 - PR Newswire
    Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy
    Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy PR Newswire
    01.11.23 - PR Newswire
    Exact Sciences Announces Third-Quarter 2023 Results
    Exact Sciences Announces Third-​Quarter 2023 Results PR Newswire
    01.11.23 - PR Newswire
    Exact Sciences to participate in November investor conferences
    Exact Sciences to participate in November investor conferences PR Newswire
    22.10.23 - PR Newswire
    Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection
    Next-​Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for ...
    20.10.23 - PR Newswire
    Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress
    Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress PR Newswire
    09.10.23 - PR Newswire
    Exact Sciences schedules third quarter 2023 earnings call
    Exact Sciences schedules third quarter 2023 earnings call PR Newswire
    09.10.23 - PR Newswire
    Exact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023
    Exact Sciences to Present Late-​Breaking Data from Pivotal BLUE-C Study on Next-​Generation Cologuard at ACG 2023 PR Newswire
    01.09.23 - PR Newswire
    Exact Sciences to participate in September investor conference
    Exact Sciences to participate in September investor conference PR Newswire
    30.08.23 - PR Newswire
    Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials
    Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials PR Newswire
    21.08.23 - PR Newswire
    Not a Wall, But an Obstacle Course: New Findings Reveal Why 45-Year-Olds Are Avoiding Colorectal Cancer Screenings
    Not a Wall, But an Obstacle Course: New Findings Reveal Why 45-Year-​Olds Are Avoiding Colorectal Cancer Screenings PR Newswire
    01.08.23 - PR Newswire
    Exact Sciences Announces Second-Quarter 2023 Results
    Exact Sciences Announces Second-​Quarter 2023 Results PR Newswire
    10.07.23 - PR Newswire
    Exact Sciences schedules second quarter 2023 earnings call
    Exact Sciences schedules second quarter 2023 earnings call PR Newswire
    23.06.23 - wallstreet:online Zentralredaktion
    Krebsfrüherkennung : Biotech-Kursrakete Exact Sciences: +90 Prozent in diesem Jahr! Geht da noch was?
    Die Aktie des US-​Biotech-Unternehmens Exact Sciences ist in diesem Jahr um fast 90 Prozent gestiegen. Doch ein Fondsmanager ist überzeugt: Die Rally ist noch nicht vorbei! ...
    21.06.23 - PR Newswire
    Thinking about trading options or stock in Tesla, Microsoft, Exact Sciences, Coinbase Global, or Logitech International?
    Thinking about trading options or stock in Tesla, Microsoft, Exact Sciences, Coinbase Global, or Logitech International? PR Newswire
    21.06.23 - PR Newswire
    Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations
    Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations PR Newswire

    Newssuche

    Videos

    newspaper
    09:30 Uhr +21,14%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »